{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:52:01Z","timestamp":1785775921342,"version":"3.56.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,2]]},"abstract":"<jats:p>Gastroesophageal reflux disease (GERD) occurs in approximately two-thirds of all pregnancies. Around 25% of pregnant women experience heartburn daily. Symptomatic GERD usually presents in the first trimester and progresses throughout pregnancy. The treatment goal is to alleviate heartburn and regurgitation without jeopardizing the pregnancy or its outcome. An English language electronic literature search of MEDLINE, EMBASE, and Cochrane Reviews was undertaken to identify randomized controlled trials, observational studies, management recommendations and reviews of GERD and its treatment during pregnancy. The search period was defined by the date of inception of each database. The treatment in a pregnant GERD patient should follow the step-up approach, starting with lifestyle modification as the first step. If heartburn is severe, medication should be started after consultation with a physician (Recommendation Grade C). The preferred choice of antacids is calcium-containing antacids (Recommendation Grade A). If symptoms persist with antacids Sucralfate can be introduced at a 1g oral tablet, 3 times daily (Recommendation Grade C). Followed by histamine-2 receptor antagonist (Recommendation Grade B). Inadequate control while on histamine-2 receptor antagonist and antacid may mandate a step-up to proton pump inhibitors along with antacids as rescue medication for breakthrough GERD (Recommendation Grade C). This article presented the treatment recommendations for pregnant women with typical GERD, based on the best available evidence.<\/jats:p>","DOI":"10.1097\/md.0000000000030487","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:20:21Z","timestamp":1662135621000},"page":"e30487","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":34,"title":["Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: A review"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-0702","authenticated-orcid":false,"given":"Mansour","family":"Altuwaijri","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2036.2011.04774.x","article-title":"Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease","volume":"34","author":"Becher","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and epidemiology of gastroesophageal reflux disease","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterology"},{"key":"R4-20250504","first-page":"1411","article-title":"Heartburn in pregnancy","volume":"2015","author":"Vazquez","year":"2015","journal-title":"BMJ Clin Evid"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pop.2017.07.001","article-title":"Gastroesophageal reflux disease","volume":"44","author":"Kellerman","year":"2017","journal-title":"Prim Care"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2005\/836030","article-title":"Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004","volume":"19","author":"Armstrong","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"R7-20250504","first-page":"541","article-title":"Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents","volume":"65","author":"Quartarone","year":"2013","journal-title":"Minerva Ginecol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1440-1746.1998.tb00564.x","article-title":"Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women","volume":"13","author":"Ho","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1572-0241.2007.01452.x","article-title":"Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study","volume":"102","author":"Rey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1471-0528.1992.tb13873.x","article-title":"Determinants of pregnancy heartburn","volume":"99","author":"Marrero","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8553(02)00065-1","article-title":"Gastroesophageal reflux disease during pregnancy","volume":"32","author":"Richter","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0016-5085(77)80151-0","article-title":"Heartburn of pregnancy","volume":"72","author":"Van","year":"1977","journal-title":"Gastroenterology"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1023\/A:1017992808762","article-title":"Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease","volume":"47","author":"Ho","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R14-20250504","first-page":"391","article-title":"[GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice]","volume":"103","author":"Schunemann","year":"2009","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-013-0101-8","article-title":"Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment","volume":"73","author":"Hom","year":"2013","journal-title":"Drugs"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2036.2003.01679.x","article-title":"Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting","volume":"18","author":"Tytgat","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2005.02654.x","article-title":"Review article: the management of heartburn in pregnancy","volume":"22","author":"Richter","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-20250504","first-page":"143","article-title":"Treatment of heartburn and acid reflux associated with nausea and vomiting during pregnancy","volume":"56","author":"Law","year":"2010","journal-title":"Can Fam Physician"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/gut.42.1.13","article-title":"Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis","volume":"42","author":"Eggleston","year":"1998","journal-title":"Gut"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bpg.2007.05.006","article-title":"Gastroesophageal reflux disease in pregnancy.","volume":"21","author":"Ali","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamasurg.2015.4233","article-title":"An evidence-based approach to the treatment of gastroesophageal reflux disease","volume":"151","author":"Patti","year":"2016","journal-title":"JAMA Surg"},{"key":"R26-20250504","first-page":"1411","article-title":"Constipation, haemorrhoids, and heartburn in pregnancy.","volume":"2008","author":"Vazquez","year":"2008","journal-title":"Clin Evid"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ncpgasthep1197","article-title":"The spectrum and treatment of gastrointestinal disorders during pregnancy","volume":"5","author":"Keller","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MCG.0000000000001399","article-title":"Short meal-to-bed time is a predominant risk factor of gastroesophageal reflux disease in pregnancy","volume":"55","author":"Quach","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"R30-20250504","first-page":"346","article-title":"Associations between sleep position and nocturnal gastroesophageal reflux: a study using concurrent monitoring of sleep position and esophageal pH and impedance","volume":"117","author":"Schuitenmaker","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/aim.2009.000497","article-title":"Acupuncture for dyspepsia in pregnancy: a prospective, randomised, controlled study","volume":"27","author":"da Silva","year":"2009","journal-title":"Acupunct Med"},{"key":"R32-20250504","first-page":"CD011379","article-title":"Interventions for heartburn in pregnancy","volume":"2015","author":"Phupong","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1447-0756.1990.tb00361.x","article-title":"Is mucaine an appropriate medication for the relief of heartburn during pregnancy?","volume":"16","author":"Kovacs","year":"1990","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"R34-20250504","first-page":"680","article-title":"Pyrosis and pregnancy","volume":"13","author":"Reisfield","year":"1971","journal-title":"Curr Ther Res Clin Exp"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365528909093066","article-title":"Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis","volume":"24","author":"Weberg","year":"1989","journal-title":"Scand J Gastroenterol"},{"issue":"5 Suppl","key":"R36-20250504","first-page":"79S","article-title":"The effects of chronic gastrointestinal medication on the fetus and neonate","volume":"58","author":"Witter","year":"1981","journal-title":"Obstet Gynecol"},{"key":"R37-20250504","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule","volume":"79","year":"2014","journal-title":"Fed Regist"},{"key":"R38-20250504","first-page":"2","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems [Systematic Review]","volume":"2","author":"Hofmeyr","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.gastro.2006.04.049","article-title":"American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy","volume":"131","author":"Mahadevan","year":"2006","journal-title":"Gastroenterology"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5694\/j.1326-5377.2005.tb06735.x","article-title":"Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy","volume":"182","author":"Gordon","year":"2005","journal-title":"Med J Aust"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1742-1241.2003.tb10458.x","article-title":"An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy","volume":"57","author":"Lindow","year":"2003","journal-title":"Int J Clin Pract"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bpg.2007.06.002","article-title":"Gastrointestinal medications in pregnancy","volume":"21","author":"Mahadevan","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R44-20250504","first-page":"91","article-title":"Sucralfate in the treatment of pregnancy pyrosis.","volume":"12","author":"Ranchet","year":"1990","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0091270009350483","article-title":"The safety of H(2)-blockers use during pregnancy","volume":"50","author":"Matok","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0029-7844(97)00126-9","article-title":"Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy","volume":"90","author":"Larson","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10620-008-0587-1","article-title":"The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis","volume":"54","author":"Gill","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ajg.2009.122","article-title":"The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis","volume":"104","author":"Gill","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1023\/A:1015863018105","article-title":"Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis","volume":"47","author":"Nikfar","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","article-title":"Use of proton-pump inhibitors in early pregnancy and the risk of birth defects","volume":"363","author":"Pasternak","year":"2010","journal-title":"N Engl J Med"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/11597290-000000000-00000","article-title":"Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date","volume":"72","author":"Majithia","year":"2012","journal-title":"Drugs"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0029-7844(97)00126-9","article-title":"Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy","volume":"90","author":"Larson","year":"1997","journal-title":"Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:35:52Z","timestamp":1746333352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":48,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030487","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}